Live coverage has ended. The full story is below.
Rivian Automotive (NASDAQ: RIVN | RIVN Price Prediction) reports fourth quarter and full year 2025 earnings tonight after market close. After a volatile stretch marked by recall headlines, analyst downgrades, and a sharp stock decline, investors are looking for clarity on execution and the path forward.
Earnings Expectations
| Metric |
Q4 2025 Estimate |
YoY Growth |
FY 2025 Estimate |
| EPS (Loss) |
($.67) |
N/M |
($2.59) |
| Revenue |
$1.263 |
N/A |
(.$67) |
Wall Street is focused on vehicle delivery numbers and whether Rivian can show progress toward positive gross margins. The company delivered 42,247 vehicles for the full year, an 18% year-over-year decline attributed to softer EV market conditions and the expiration of federal tax credits.
Last Quarter’s Mixed Results
In Q3 2025, Rivian reported EPS of -$0.65, beating the estimate of -$0.74 by 12.16%. That marked a recovery from Q2’s significant miss, when the company posted -$0.97 EPS against a -$0.66 estimate.
The stock has struggled since. Shares are down 27.78% year to date and 24.49% over the past month, trading at $14.23. A 12.8% drop in mid-January followed news of a major recall, softer 2025 guidance, and a UBS downgrade to Sell.
What I’m Watching Tonight
The R2 platform is the make-or-break story. Rivian has begun producing manufacturing validation units for its mid-size SUV, targeting initial deliveries in H1 2026. Any delay or lack of clarity on pre-order demand will hurt sentiment. The R2 is positioned as Rivian’s mass-market play, and execution here determines whether the company can scale profitably.
Gross margin trajectory is critical. Last quarter showed improvement, but the company needs to demonstrate a clear path to sustained positive gross margins. I’ll be listening for updates on cost reduction initiatives and how the $5.8 billion Volkswagen joint venture is progressing.
Cash burn remains a concern. Morningstar has flagged projected negative free cash flow for several years, and investors need to see discipline in capital allocation. The recall of R1T and R1S models adds uncertainty around near-term costs and production capacity.
Insider activity has been overwhelmingly negative. CEO RJ Scaringe sold 69,795 shares across six transactions between November and January, with sales ranging from $15.11 to $21.43 per share. CFO Claire McDonough disposed of 59,428 shares in December. No insiders have made discretionary purchases at market prices in recent months.
This Quarter Sets the Tone
Rivian needs to show it can execute on R2, control costs, and stabilize delivery trends. The company has the capital backing from Volkswagen and a differentiated product, but the path to profitability remains long. If management can provide a credible timeline for gross margin improvement and R2 ramp, sentiment could stabilize. If execution concerns persist, the stock will likely remain under pressure.
Contact [email protected] for any questions or corrections.